No title
Avian malaria, caused by Plasmodium parasites, commonly persists as a chronic infection, yet reliable treatment protocols remain insufficiently evaluated. Assessing treatment efficacy is essential for improving disease management and understanding impacts on host health. We conducted a 2.5-year experimental study to assess the efficacy and safety of atovaquone-proguanil (Malarone®) against Plasmod
